Interestingly, improved survival was observed for Rh-negative individuals with non-ischaemic cardiomyopathy during the initial 2 years of follow-up, with curves on time-to-event analysis starting to converge after that and finally overlapping at 3 years24. Here, RHD is linked to cardiomyopathy.